Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Coda Genomics, a synthetic biology company, has signed a collaboration agreement with Genencor, a division of Danisco, a biotechnology company that develops and markets enzymes and bio-based products.
Subscribe to our email newsletter
Under the terms of the agreement, Coda will utilize its proprietary suite of technologies to create highly diverse and complex libraries of synthetic genes and proteins for Genencor. Genencor will screen these libraries for use in future research programs.
Bill Radany, CEO of Coda Genomics, said: “Coda’s capabilities in synthetic biology have been used to solve many complicated proteomic problems across agricultural and pharmaceutical R&D programs.
“Our collaboration with Genencor is a testament to our ability to apply our synthetic, proprietary technologies and methods to generate novel protein molecules to meet our client’s unique needs.”